Ganglioside composition and histology of a spontaneous metastatic brain tumour in the VM mouse by El-Abbadi, M et al.
Cancer metastasis is a complex problem that involves intrinsic
properties of the metastatic tumour cells as well as interactions
between these cells and the host immune system (Nicolson, 1984;
Kanda et al, 1992). Metastatic tumour cells are distinguished from
nonmetastatic tumour cells by their ability to move from a primary
tumour site to a distant location where they adhere and grow.
Alterations in the cell surface glycocalyx may underlie the
metastatic potential of some tumour cells (Kim et al, 1975;
Hakomori, 1996). 
Gangliosides are sialic acid-containing glycosphingolipids
(GSLs) that are enriched in the outer leaflet of plasma membranes.
Marked changes occur in the content and distribution of ganglio-
sides in association with brain tumour formation in both man and
mouse (Seyfried et al, 1987; 1992; Fredman, 1988; Yates, 1988;
Sung et al, 1994, 1995). Some of these changes are intrinsic to the
neoplastic tumour cells and others are associated with the invasion
of tumour-infiltrating host cells (El-Abbadi and Seyfried, 1994;
Seyfried et al, 1996). Because gangliosides are major components
of the cell surface glycocalyx and participate in cell–cell and
cell–matrix interactions, they have been implicated in the inva-
sive/metastatic properties of tumour cells (Kanda et al, 1992;
Coulombe and Pelletier, 1993; Zebda et al, 1995; Hakomori, 1996;
Bai and Seyfried, 1997; Fang et al, 1997; Ruggieri et al, 1999;
Deng et al, 2000). 
In this study, we analysed the ganglioside composition of 
a spontaneous malignant brain tumour in the VM mouse.
Spontaneous tumours of the central nervous system (CNS) are rare
in mice and occur with an overall incidence of about 0.01%
(Swenberg, 1982; Morgan et al, 1984). The VM mouse strain is
unique in this regard by expressing a high incidence (about 1.5%)
of spontaneous CNS tumours that appear histologically as astrocy-
tomas (Fraser, 1971, 1986). The VM brain tumour described here
is highly metastatic and its ganglioside content is significantly
influenced by in vivo and in vitro growth environments. 
MATERIALS AND METHODS 
Mice 
VM mice were obtained originally as a gift from Dr George
Carlson, McLaughlin Research Institute, Montana. All VM mice
used in this study were propagated in the animal room of the
Biology Department, Boston College, using animal husbandry
conditions described previously (Flavin et al, 1991). A 425-day-
old mouse from this colony showed enlargement of the head,
lethargy and tremor. This mouse was killed by cervical dislocation
and a tumour was grossly identified in a cerebral hemisphere
showing a poorly defined 3 ´ 1 ´ 1 mm mass with regions of soft-
ening. The tumour was minced, suspended in phosphate-buffered
saline (PBS), and was then implanted intracranially (i.c.) into 3
syngeneic VM mice. After 3 i.c. passages of the original tumour,
serial subcutaneous (s.c.) transplants into the flank were initiated
as described previously (El-Abbadi and Seyfried, 1994). Flank
tumours became grossly evident within 8–10 days of transplanta-
tion, and death usually occurred within 4–6 weeks. VM mice,
approximately 2–3 months of age, were used as tumour recipients.
All animal use procedures were in accordance with the National
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Animals and were approved by the Institutional Care Committee.
Also, these procedures meet the standards required by the UKCCCR
guidelines. 
Histological analysis 
Complete autopsies were performed to characterize the VM
tumour and its metastatic involvement at 16, 20 and 30 days after
flank implantation of the tumour tissue. Routine haematoxylin and
eosin (H&E) staining was used to assess the histological appear-
ance of primary and metastatic lesions. Immunohistochemical
techniques were performed on both fresh-frozen and paraffin-
embedded tumour tissues using the standard 3-step indirect 
peroxidase-antiperoxidase method (Sternberger, 1979). Primary
antibodies were used for immunohistological analysis of the
following proteins (a) neuroectodermal S-100 protein (BioGenex)
(Kahn et al, 1983); (b) neuron-specific enolase (NSE) (Vinores
et al, 1984); (c) neurofibrillary protein (NFP) (BioGenex)
(Schlaepfer, 1987); (d) glial fibrillary acidic protein (GFAP) (Eng,
1985); (e) leukocyte common antigen (LCA) (Dako and ATCC)
(Powers et al, 1992); (f) Mac-1a (Sanchez Madrid et al, 1983); (g)
B cell surface glycoprotein (B 220) (Coffman and Weissman,
1981); and (h) intercellular adhesion molecule (ICAM-1) (Said et
al, 1979). The antibodies were titrated against known positive
tissues to determine the optimal concentrations to be used. For
ultrastructural examination, the tumour tissue was fixed for 2 h at
room temperature with 2.5% glutaraldehyde in 0.2 M cacodylate
buffer (pH 7.2). Following post fixation in 2% osmium tetroxide
for one hour at 4˚C, the tissue was dehydrated and embedded in an
epon mixture, sectioned, and stained in uranyl acetate and lead
citrate for 15 min and 10 min, respectively. Tissue sections were
examined using a Philips 300 electron microscope. 
Ganglioside analysis 
The solid tumours, normal mouse brains, and cultured tumour
cells were frozen at –20˚C, and were then lyophilized to remove
water. Gangliosides were isolated and purified by our previously
described methods (Seyfried et al, 1978, 1987). The purified
gangliosides were treated with mild base and then desalted using
C-18 Bond Elute columns. Quantification of N-acetylneuraminic
acid (NeuAc) and N-glycolylneuraminic acid (NeuGc) was deter-
mined using a gas-liquid chromatography procedure (Yu and
Ledeen, 1970). Sialic acid concentration was expressed as mg 100
mg–1 dry weight. The distribution of tumour gangliosides was
examined using high performance thin-layer chromatography
(HPTLC) (Whatman HPK silica gel) according to the method of
Ando et al, 1978. The mouse brain tumour gangliosides were
compared with gangliosides isolated from the cerebral cortex of
normal adult mice and with purified GM3, GM3-NeuGc, GM2,
GM2-NeuGc, GM1, GD3, GD1a, GT1a, GD1b, GT1b, and GQ1b
isolated from mouse, bovine and human tissues by the method of
Ando and Yu (Ando and Yu, 1977, 1979). The conditions for
HPTLC development are described in Figure 3. 
Ganglioside biosynthesis in cultured tumour cells 
The VM tumour cell line was established from the flank growing
tumour as previously described for other mouse brain tumours
(Seyfried et al, 1992; El-Abbadi and Seyfried, 1994). Ganglioside
studies were conducted on confluent cell cultures that had a
minimum of 10 passages. The cells were grown in T-75 cultured
flasks until preconfluency. An aliquot of 14C-galactose (New
England Nuclear) equivalent to 3–5 mCi was evaporated to
dryness under N2 and resuspended in 10 ml of complete
Dulbecco’s modified Eagle medium (DMEM). After passage
through a sterile filter, the radiolabel-containing medium was fed
to the cells. The cells were grown for 48 h (confluency stage) at
37˚C. The medium containing 14C-galactose was discarded and the
flask rinsed 3 ´ with 5 ml of sterile, cold PBS. Next, the cells were
trypsinized, collected in cold, sterile PBS, and centrifuged for 3
min at 2000 rpm. The pellet was washed twice with PBS, frozen,
and finally lyophilized to dryness. Radiolabled gangliosides,
synthesized by the cells, were isolated and purified as described
above. Prior to ganglioside isolation, about 10 mg of unlabelled
mouse brain ganglioside sialic acid were added to each sample 
as carrier. Approximately 3800 dpm of 14C-labelled gangliosides
were spotted on the HPTLC plate. 
Gangliosides from the VM cell line were treated with
Clostridium perfringens neuraminidase (Type V). Neuraminidase
removes terminal sialic residues from gangliosides and will
convert hematosides (GM3 and GD3) to lactosylceramide, and
polysialogangliosides to GM1 (Ando and Yu, 1977). Gangliosides
GM1 and GM2 are mostly unaffected by neuraminidase treatment
since they carry an internal sialic acid. The enzymatic hydrolysis
was done as previously described (Ando and Yu, 1977). An aliquot
of 5800 dpm of the radiolabelled purified tumour cell gangliosides
was dried under N2, then dissolved in 140 ml of 0.1 M sodium
acetate buffer (pH 5.0). Next, 50 ml of neuraminidase (1 unit ml–1
buffer) and 15 ml of 2% Triton CF-54 were added and the mixture
was incubated for 24 hours at 37˚C in a shaking water bath. The
reaction was stopped by boiling the mixture for 4 minutes. The
reaction product was treated with mild base (0.1 N NaOH),
desalted, resuspended in C:M (1:1) and finally spotted on HPTLC.
Autoradiography of labelled gangliosides was performed by
exposing the HPTLC plate to Hyperfilm-3H (Amersham,
Arlington Heights, IL) for 14 days at room temperature. The
exposed film was then developed for 5 min and fixed for 4 minutes
in Kodak GBX developer and fixer. 
RESULTS 
Histological analysis 
Gross examination of the flank implanted tumours disclosed a
whitish, solid, lobulated mass with areas of necrosis. Metastases of
the tumour to brain, liver, spleen, and regional lymph were noted
at the complete autopsy. Metastases to other organs were identified
only by histologic examination. The most common and earliest
sites to become involved with metastatic tumour were the brain,
spleen, regional lymph nodes, vertebrae and spinal cord. Brain
metastases were malignant and metastatic when transplanted
subcutaneously into the flanks of other VM mice. Interestingly, no
metastases occurred if the tumour was maintained through
intracranial transplantation. The gross autopsy findings are
summarized in Table 1. 
By light microscopy, the tumour was diffusely infiltrating,
highly cellular, and had a relatively uniform appearance (Figure
1A). The tumour cells had small amounts of cytoplasm, were
poorly differentiated, and were supported by a delicate fibrovas-
cular stroma. The tumour cell nuclei were centrally located, round
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nent nucleoli. Mitotic figures and regions of necrosis were
frequently seen, but nuclear pleomorphism was mild. The histo-
logic features of the metastatic tumour foci in other organs were
basically the same as those of the flank tumours. All but one
animal had brain involvement with multiple foci of metastases
consisting of diffuse infiltration of superficial cortex, perivascular
Virchow-Robin’s spaces of the grey and white matter, and
subependymal regions (Figure 1B and C). No metastases to the
vertebrae and spinal cord were seen after 16 days, but were present
in all animals 20 and 30 days after flank implantation. In affected
animals there was infiltration of tumour cells into dura mater of the
spinal cord and peripheral nerve root (Figure 1D). 
Organomegaly at autopsy identified early tumour involvement
in regional lymph nodes and spleen. Metastases to liver and lung
occurred later. Involvement of kidney was sporadic, occurring in
at least 1 of 3 animals at each time following implantation.
Microscopic examination disclosed multiple subcapsular metas-
tases of the liver and diffuse infiltration of tumour cells into the
sinusoids of the regional lymph nodes and spleen. Subcapsular and
cortical metastases were noted in the kidney. The tumour involved
the muscle of the flank near the implantation site suggesting direct
invasion of the tumour cells into neighbouring muscle. The tumour
cells also infiltrated into the subcutaneous fatty tissue of the flank.
A pericardial metastasis was noted in one animal. 
Staining for all neuroectodermal, neuronal, and glial markers
(S-100, NSE, NFP and GFAP) were negative in both the implanted
flank tumours and in the secondary metastatic tumours. The
lymphoid markers (LCA) were mostly negative. In the metastatic
spleen, however, there was a weakly positive reaction against B-
220 (B lymphocyte marker) and a few positive cells were seen
with Mac-1a (macrophage marker) and with ICAM-1 (prolifer-
ating lymphocytes and endothelial cells (not shown). 
By electron microscopy, the tumour consisted of cells (15 to
20 mm in diameter) that had regular, slightly indented nuclei
(Figure 2A). These cells contained densely clumped heterochro-
matin, prominent nucleoli, and had scant cytoplasm with only a
small number of cytoplasmic organelles (Figure 2A and 2B).
Groups of tumours cells were surrounded by attenuated fibroblasts
with rough endoplasmic reticulum and long fibrillary cytoplasmic
processes that were interposed between the tumour cells. The
processes mimicked subplasmalemmal densities (Figure 2B).
Frequent mitotic figures were noted. No intermediate filaments,
microtubules, neurosecretory granules or cell processes were seen.
The tumour cells had smooth, closely apposed membranes with no
specific junctional structures (Figure 2C). 
Ganglioside analysis 
The ganglioside sialic acid content of the VM tumour and cultured
VM tumour cells is shown in Table 2. The total ganglioside sialic
acid content of the s.c. and i.c. VM tumours was significantly
lower than the content of the normal VM mouse brain (337.1 ±
10.5 mg NeuAc/100 mg dry weight; n = 3). No NeuGc containing
gangliosides were found in the brain. The ganglioside content in
the s.c. tumour was very low and consisted mostly of NeuGc-
containing gangliosides. The total sialic acid content was higher in
the i.c. tumour than in s.c. tumour. This was due to a significant
increase in NeuAc-containing gangliosides. This increase comes
from the contamination of the tumour tissue with ganglioside-rich
tissue from normal brain as we previously described for other
mouse brain tumours (Seyfried et al, 1987; El-Abbadi and
Seyfried, 1994). Normal neural tissue also contributes to the
higher NeuAc ganglioside content in the brain metastasis (brain
met.) than in s.c. tumour. 
The i.c. tumour and the brain met. contained several ganglio-
sides that co-migrated on HPTLC with mouse brain gangliosides
(compare lanes 3, 4 and 6 in Figure 3). Several of these ganglio-
sides (GD1a, GD1b, GT1b, and GQ1b) were absent or reduced in
the s.c. tumour (lane 5). Most of these brain gangliosides originate
from mouse brain tissue surrounding or entrapped within the
tumour (Seyfried et al, 1987; El-Abbadi and Seyfried, 1994). 
The ganglioside patterns of the i.c. tumour and the brain met. were
similar (lanes 4 and 6, respectively). Furthermore, these patterns
represented a composite of the brain pattern (lane 3) and the s.c.
tumour pattern (lane 5). The ganglioside pattern of the s.c. tumour
was complex and contained several gangliosides that did not
migrate on HPTLC with standard brain gangliosides (lane 5). A
prominent band was seen migrating in the region of GM1b and
multiple bands migrated in the region of GD1a/GT1a. 
Striking differences in ganglioside content were found between
the VM tumour grown in vivo and in vitro. The total ganglioside
content and the content of NeuAc-containing gangliosides was
about 20-fold higher and 70-fold higher, respectively, in the
Composition of a spontaneous metastatic brain tumour 287
British Journal of Cancer (2001) 85(2), 285–292 © 2001 Cancer Research Campaign
Table 1 Metastatic involvement of the spontaneous VM tumour 
Tissues examineda
Duration of   Tumour  Lymph  Skeletal  Heart Lung Liver Spleen Kidney Brain Spinal cord
tumour growth weight (g) node muscle
(days)
16 0.30 – – – – – – – – – 
0.39 – – +b –– ++ + –  
0.37 + – – – – + – + – 
20 0.51 – – – – + + – + + 
0.57 + – – – – + + + + 
0.61 + + – – – + + + + 
30 4.27 + – –c –c ++ ++ +  
4.41 + + – + + + – + + 
4.50 + + – + + + + + + 
a + and – indicate the presence or absence of tumour, respectively. b Pericardial metastasis was noted. c Intravascular tumour emboli were detected. cultured cells than in the s.c. tumour (Table 2). In contrast to the
s.c. tumour, no NeuGc-containing gangliosides were detected in
the cultured VM cells. GM3-NeuAc, GM2-NeuAc, GM1 (minor
ganglioside), and GD1a were the predominant gangliosides in the
VM cultured cells (Figure 4, lane 4). The same gangliosides were
radiolabelled when the cells were grown in media containing 14C-
galactose (Figure 4, lane 5). The ganglioside pattern in the
cultured VM cells was less complex than the pattern observed in
the tumour grown in vivo (compare lane 5, Figure 3 with lane 4,
Figure 4). 
The products of neuraminidase treatment of the radiolabelled
gangliosides isolated from cultured VM cells is shown in Figure 4
(lane 6). Neuraminidase treatment converted several gangliosides
to more simple structures. Specifically, the hydrolysis resulted in
appearance of a double band in the lactosyl ceramide region, the
disappearance of the double bands migrating with gangliosides
GM3-NeuAc and GD1a, and an increase in the intensity of the
double band migrating with GM1. These results indicate that
GM3, GM2, GM1 and GD1a are the major gangliosides synthe-
sized by the cultured VM tumour cells. Furthermore, the double
band appearance of these gangliosides arises from heterogeneity in
ceramide structure as described previously (Seyfried et al, 1987;
El-Abbadi and Seyfried, 1994; Bai and Seyfried, 1997). A minor
double band appeared above GM3 that migrated with standard
GA2 (lane 6). The presence of Triton CF-54 in the neuraminidase
reaction allows the neuraminidase to partially hydrolyse the
internal sialic acid of GM2, thus producing GA2 (Li et al, 
1980). 
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Figure 1 Light microscopic appearance of the VM tumour 20 days after flank (s.c.) implantation. (A) The s.c. tumour consists of poorly differentiated, uniform,
round cells with scant cytoplasm (H&E ´ 400). (B–D) Metastases from the s.c. VM tumour. (B) Metastatic tumour cells in the arachnoid (H&E ´ 400).
(C) Metastatic tumour cells in frontal lobe (H&E ´ 100). (D) Metastatic tumour cells to vertebrae and arachnoid of the spinal cord (H&E, ´ 20) DISCUSSION 
We have characterized the histology and ganglioside composition
of a new and highly malignant brain tumour in the VM mouse
strain. The tumour is unique because it arose spontaneously and
metastasized to several organ systems including brain and spinal
cord after simple s.c. inoculation of tumour tissue. Extensive
metastasis distinguishes this VM brain tumour from other
described VM mouse brain tumours and from most other
metastatic murine tumour models that often require repeated in
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Figure 2 Electron microscopic appearance of the VM tumour 20 days after flank (s.c.) implantation. (A) Medium-sized tumour cells (15–20 mM) surrounded by
attenuated fibroblasts which have elongated fibrillary cytoplasmic processes (arrow) (´ 2800); (B) Tumour cells have few mitochondria (M), single ribosomes
(R), scant endoplasmic reticulum (er) and have closely apposed smooth membranes (´ 12 800). The arrows indicate small, discrete interposition of fibrillary
cytoplasmic processes between the tumour cells that mimic subplasmalemmal densities. (C) The tumour cells maintain their smooth outlines. There are no
intermediate filaments, microtubules, neurosecretory granules, or cell processes. A nucleus undergoing mitosis is noted (arrows) (´ 38 400) vivo selection of brain colonizing variants from tumour cell lines
that routinely metastasize to nonneural organs (Bosmann et al,
1973; Brunson et al, 1978; Conley, 1984; Schackert et al, 1988).
Hence, this new VM tumour should be useful as a natural model
for human metastatic cancer. 
Although this VM tumour is highly metastatic when implanted
subcutaneously, it does not metastastize to non-CNS organs when
implanted into the brain. Extracranial metastasis is also generally
rare for most primary human brain tumours (Duffy, 1983; Shapiro,
1986; Pedersen et al, 1994; Vural et al, 1996). The explanation for
this is unknown, but it may be related to the immunologically priv-
ilaged nature of the brain or to the inability of VM cells to adhere
and/or degrade brain vascular endothelium. The VM brain tumour
may therefore serve as a model for investigating these processes. 
The poorly differentiated appearance the VM tumour cells
under light microscopy is consistent with previous observations in
other VM tumours (Serano et al, 1980; Pilkington et al, 1985).
Although the VM brain tumours described by H Fraser appeared
histologically as astrocytomas (Fraser, 1971, 1986), it was not
possible for us to classify the metastatic VM brain tumour as an
astrocytoma since no positive staining was seen with GFAP, NSE,
NFP or S-100 protein. It is important to mention, however, that
Fraser examined the histology of primary VM tumours at their site
of origin, while we examined the histology of our VM tumour
following serial passage. This could account in part for some of
the histological differences between studies on VM tumours since
tumour microenvironment can influence tumour histology
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Figure 3 Thin-layer chromatogram of VM tumour gangliosides from
tumours grown in VM mice. Lane 1, purified ganglioside standards. GT1a
and disialoparagloboside (LD1) co-migrate in this solvent system; lane 2,
GM3-NeuGc and GM2-NeuGc standards; lane 3, adult VM mouse brain
gangliosides; lane 4, gangliosides from tumour grown intracerebrally; lane 5,
gangliosides from tumour grown subcutaneously in the flank; lane 6,
gangliosides from brain metastases in mice carrying the tumour in the flank.
The plate was developed by one ascending run with chloroform: methanol:
water (55:45:10 by volume) that contained 0.02% CaCl2:2H2O. Approximately
2.0 mg of total ganglioside sialic acid were spotted onto each lane. After
development, the bands were visualized by the resorcinol spray 
Lac-Cer
GM3-NA
GM3-NG
GM2-NA/GM2-NG
GM1
GD3
GD1a
GT1a/LD1
GD1b
GT1b
GQ1b
12 3 4 56
Figure 4 Thin-layer chromatogram of gangliosides in cultured VM tumour
cells. Lane 1, ganglioside standards; lane 2, GM3-NeuGc and GM2-NeuGc
and GM1b standards; lane 3, adult VM brain gangliosides; lane 4,
gangliosides in cultured VM tumour cells; lane 5, autoradiogram of
radiolabelled gangliosides synthesized by cultured VM cells; lane 6,
autoradiogram of neuraminidase-treated gangliosides synthesized by
cultured VM cells. For radiolabelling, cells were grown for 48 h in media
containing 14C-galactose. After isolation and purification of labelled tumour
cell gangliosides, an aliquot containing about 1900 dpm was spotted onto the
HPTLC plate (lane 5). For C. perfringens neuraminidase treated samples
(lane 6), an aliquot containing about 5400 dpm was spotted onto HPTLC
plate. Approximately 2.0 mg of total ganglioside sialic acid were spotted for
each of unlabelled lanes (lane 1–4). The plate was developed by one
ascending run with chloroform:methanol:water that contained 0.02%
CaCl2:2H2O; (55:45:10 by volume). The dried plates were exposed to
Hyperfilm-3H. After autoradiography, the plates were sprayed with the
resorcinol reagent to identify lanes with unlabelled gangliosides 
Table 2 Ganglioside content of the spontaneous metastatic VM brain tumour and
cultured VM tumour cells 
Ganglioside neuraminic acid contenta
(mg 100 mg–1 dry wt) 
VM tumour  Nb Total NeuAc NeuGc 
Solid tumour 
S.C.c 6 12.6 ± 0.9 3.6 ± 0.6 8.9 ± 0.8 
I.C.d 3 30.5 ± 7.9 24.6 ± 7.7 5.9 ± 0.3 
Brain Met.e 3 15.5 ± 1.8 8.1 ± 2.0 7.5 ± 0.4 
Cultured cellsf 3 248.4 ± 4.4 248.4 ± 4.4 NDg
a NeuAc, N-acetylneuraminic acid; NeuGc, N-glycolylneuraminic acid. b N, Number of
independent samples studied. Values are expressed as means ± SEM. c S.C.,
subcutaneously grown tumour.d I.C., intracerebrally grown tumour. e Brain Met., brain
metasteses collected from mice carrying VM tumour in the flank. f Cultured VM cells were
derived from the solid VM tumour as described in the Materials and Methods. g ND, not
detectable. (Seyfried, 2001). Our electron microscopic examination also
revealed a poorly differentiated tumour with a sparse interstitial
matrix and closely apposed cell surface. Based on the weak
immunostaining of the VM tumour with B220, we cannot exclude
the possibility of lymphoma. Further studies will be needed to
better classify this tumour. 
The ganglioside content of this tumour was different from that
of previously described mouse brain tumours. In contrast to most
experimental mouse brain tumours, which contain between 20–70
mg total ganglioside sialic acid/100 mg dry weight when grown
subcutaneously in vivo (Seyfried et al, 1987, 1992), the total
ganglioside sialic acid content of the VM tumour was only about
13 mg. Furthermore, about 70% of this sialic acid was in the form
of NeuGc. Our previous studies showed that much of the NeuGc-
containing gangliosides found in mouse brain tumours is
contributed by the host environment, e.g., serum and tumour-infil-
trating macrophages (Ecsedy et al, 1998; El-Abbadi and Seyfried,
1994; Seyfried et al, 1996, 1998). Our findings suggest that the
total ganglioside content of the neoplastic VM tumour cells is
diminished when grown in vivo. 
Differences in growth environment (in vivo versus in vitro)
significantly influenced the ganglioside content of the metastatic
VM tumour. In contrast to the in vivo-grown VM tumour, which
contained a low total ganglioside content, the ganglioside sialic
acid content of the cultured VM tumour cells was high (Table 2).
Indeed, this content was much higher than that found previously in
20-methylcholanthrene-induced experimental mouse brain tumour
cell lines (about 38–82 mg 100 mg–1 dry weight) (Seyfried et al,
1992). Muthing and coworkers previously reported that differ-
ences in the in vitro growth environment could significantly influ-
ence the ganglioside composition of mouse lymphoma cells
(Muthing et al, 1992). Differences in growth environment can also
influence the ganglioside distribution of human brain tumours
(Wikstrand et al, 1994; Fredman et al, 1996). 
It is unlikely that the low ganglioside content of the in vivo-
grown VM tumour results from a tumour-shedding phenomenon
since serum ganglioside content is lower in tumour-bearing VM
mice than in nontumour-bearing VM mice (Cotterchio and
Seyfried, 1994). This contrasts with previous findings in the
murine AKR lymphoma and ependymoblastoma which shed
gangliosides (Ladisch et al, 1987; Manfredi et al, 1999). Since
most gangliosides in serum are derived from the liver, we previ-
ously suggested that the low serum ganglioside content in the
tumour-bearing VM mice may result from impaired liver function
due to liver metastasis (Cotterchio and Seyfried, 1994). The pres-
ence of VM tumour cells in liver supports this possibility. 
The low ganglioside content of the in vivo-grown VM tumour
may be associated with its high metastatic potential. Support for
this comes from previous studies that some metastatic tumours
grown in vivo contain a lower total ganglioside content than their
nonmetastatic variants (Kloppel et al, 1979; Merritt et al, 1980;
Skipski et al, 1981; Niederkorn et al, 1993; Zebda et al, 1995).
Also, an opposite effect is observed for cultured tumour cells
where the ganglioside content is generally higher in the metastatic
than the nonmetastatic cell lines (Yogeeswaran and Salk, 1981;
Yogeeswaran, 1983; Laferte et al, 1987). Our findings on the
metastatic VM brain tumour model are consistent with these
observations. Additionally, Ladisch and co-workers recently
reported a positive correlation between the ganglioside content of
murine melanoma cell lines and the metastatic potential of
resulting in vivo tumours (Deng et al, 2000). The VM tumour may
therefore serve as a model for evaluating the role of gangliosides
and other glycolipids in tumour cell invasion and metastasis. 
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